Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-09-20

Clinical Trial Update: Resveratrol-Leucine Metabolite Synergy in Pre-diabetes [NA]

View source ↗

Summary

A completed Vanderbilt University clinical trial evaluated synergy between a resveratrol-leucine metabolite for individuals with impaired glucose tolerance (pre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Resveratrol-Leucine Metabolite

Snippet

Sponsor: Vanderbilt University | Conditions: Impaired Glucose Tolerance | NA | Status: COMPLETED